FEM1A
Basic information
Region (hg38): 19:4791734-4801273
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FEM1A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 27 | 27 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 27 | 0 | 0 |
Variants in FEM1A
This is a list of pathogenic ClinVar variants found in the FEM1A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-4791931-G-A | not specified | Uncertain significance (Sep 20, 2023) | ||
19-4791966-G-T | not specified | Uncertain significance (Jun 02, 2023) | ||
19-4791970-C-G | not specified | Uncertain significance (Nov 29, 2021) | ||
19-4792009-G-A | not specified | Uncertain significance (May 07, 2024) | ||
19-4792128-G-A | not specified | Uncertain significance (Feb 27, 2024) | ||
19-4792131-G-A | not specified | Uncertain significance (Dec 16, 2022) | ||
19-4792587-G-A | not specified | Uncertain significance (Dec 11, 2023) | ||
19-4792690-A-G | not specified | Uncertain significance (Dec 07, 2021) | ||
19-4792701-G-A | not specified | Uncertain significance (May 23, 2023) | ||
19-4792732-G-C | not specified | Uncertain significance (Feb 22, 2023) | ||
19-4792800-C-T | not specified | Uncertain significance (Apr 04, 2024) | ||
19-4792875-C-G | not specified | Uncertain significance (May 30, 2024) | ||
19-4792879-C-G | not specified | Uncertain significance (Nov 24, 2024) | ||
19-4792884-C-G | not specified | Uncertain significance (Jul 11, 2023) | ||
19-4793022-T-C | not specified | Uncertain significance (May 05, 2023) | ||
19-4793091-T-G | not specified | Uncertain significance (May 25, 2023) | ||
19-4793196-G-A | not specified | Uncertain significance (Jun 09, 2022) | ||
19-4793214-A-C | not specified | Uncertain significance (Dec 19, 2022) | ||
19-4793215-G-A | not specified | Uncertain significance (Jan 31, 2022) | ||
19-4793265-G-A | not specified | Uncertain significance (Aug 12, 2024) | ||
19-4793307-C-T | not specified | Uncertain significance (Sep 21, 2023) | ||
19-4793424-C-T | not specified | Uncertain significance (Jul 17, 2024) | ||
19-4793425-G-A | not specified | Uncertain significance (Mar 14, 2023) | ||
19-4793464-C-G | not specified | Uncertain significance (Nov 18, 2022) | ||
19-4793477-G-A | not specified | Uncertain significance (Apr 25, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FEM1A | protein_coding | protein_coding | ENST00000269856 | 1 | 3844 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
8.34e-10 | 0.154 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.42 | 311 | 390 | 0.797 | 0.0000248 | 4267 |
Missense in Polyphen | 93 | 163.77 | 0.56786 | 1837 | ||
Synonymous | 0.0475 | 184 | 185 | 0.996 | 0.0000131 | 1441 |
Loss of Function | 0.407 | 15 | 16.8 | 0.893 | 8.08e-7 | 188 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Probable component of an E3 ubiquitin-protein ligase complex, in which it may act as a substrate recognition subunit (By similarity). May participate in antiinflammatory signaling via its interaction with PTGER4. {ECO:0000250}.;
- Pathway
- Post-translational protein modification;Metabolism of proteins;Neddylation
(Consensus)
Recessive Scores
- pRec
- 0.117
Intolerance Scores
- loftool
- 0.590
- rvis_EVS
- 0
- rvis_percentile_EVS
- 53.73
Haploinsufficiency Scores
- pHI
- 0.223
- hipred
- hipred_score
- ghis
- 0.521
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.924
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Fem1a
- Phenotype
- endocrine/exocrine gland phenotype; growth/size/body region phenotype; immune system phenotype; digestive/alimentary phenotype; neoplasm; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- protein ubiquitination;post-translational protein modification;negative regulation of inflammatory response;regulation of ubiquitin-protein transferase activity
- Cellular component
- cytosol
- Molecular function
- ubiquitin-protein transferase activity;EP4 subtype prostaglandin E2 receptor binding